BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12161705)

  • 1. [The anti-synthetase syndrome].
    Bergoin C; Bure M; Tavernier JY; Lamblin C; Maurage CA; Remy-Jardin M; Wallaert B
    Rev Mal Respir; 2002 Jun; 19(3):371-4. PubMed ID: 12161705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
    Häussermann A; Gillissen A; Seidel W
    Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease].
    Jordan Greco AS; Métrailler JC; Dayer E
    Rev Med Suisse; 2007 Nov; 3(134):2675-6, 2679-81. PubMed ID: 18159702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antisynthetase syndrome].
    Gran JT
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2270-2. PubMed ID: 12448266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymyositis and Jo-1 syndrome].
    Treher E; Niederhoff A; Gellissen U; Schmidt P; Dornberg M; Peter HH
    Z Rheumatol; 1993; 52(5):301-6. PubMed ID: 8259722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time].
    Hengstman GJ; van Venrooij WJ; van den Hoogen FH; van Engelen BG
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1485-9. PubMed ID: 12924076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organizing pneumonia as the first manifestation of anti-synthetase syndrome.
    Priyangika SM; Karunarathna WG; Liyanage I; Gunawardana M; Udumalgala S; Rosa C; Kulatunga A
    BMC Res Notes; 2016 Jun; 9():290. PubMed ID: 27251562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.
    Betteridge Z; Gunawardena H; North J; Slinn J; McHugh N
    Rheumatology (Oxford); 2007 Jun; 46(6):1005-8. PubMed ID: 17392287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
    Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
    Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
    Lange U; Piegsa M; Müller-Ladner U; Strunk J
    Autoimmunity; 2006 May; 39(3):261-4. PubMed ID: 16769661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].
    Katsuki Y; Hirakata M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():505-7. PubMed ID: 16111315
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-synthetase syndrome: a special subgroup of idiopathic inflammatory myopathies. Apropos of 3 case reports].
    Perret L; Salani I; Rivier G; So AK
    Praxis (Bern 1994); 1996 Apr; 85(16):508-12. PubMed ID: 8657993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatomyositis sine myositis and antisynthetase syndrome.
    Climent-Albaladejo A; Saiz-Cuenca E; Rosique-Roman J; Caballero-Rodriguez J; Galvez-Munoz J
    Joint Bone Spine; 2002 Jan; 69(1):72-5. PubMed ID: 11858361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
    Sato S; Kuwana M; Hirakata M
    Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
    Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy in the setting of the anti-synthetase syndrome.
    Rozelle A; Trieu S; Chung L
    J Clin Rheumatol; 2008 Oct; 14(5):285-8. PubMed ID: 18664993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussion.
    Respicio G; Shwaiki W; Abeles M
    Conn Med; 2007 Mar; 71(3):151-3. PubMed ID: 17405398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Jo-1 Syndrome--immunological findings and clinical manifestations].
    Seiberlich B; Hunzelmann N; Roers A; Weber M; Schulze-Lohoff E
    Med Klin (Munich); 2005 Mar; 100(3):137-42. PubMed ID: 15966441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.